Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone binding	RBBP4 SMARCC2 RBBP7 SRCAP	3.69e-05	265	15	4	GO:0042393
GeneOntologyMolecularFunction	transcription coactivator activity	SMARCC2 HMGB1 ACTN1 SRCAP	6.22e-05	303	15	4	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	SMARCC2 HMGB1 ACTN1 SRCAP	6.62e-04	562	15	4	GO:0003712
GeneOntologyMolecularFunction	nucleosomal DNA binding	RBBP4 SMARCC2	1.13e-03	67	15	2	GO:0031492
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	SMARCC2 HMGB1 ACTN1 STX12 SRCAP	1.21e-03	1160	15	5	GO:0030674
GeneOntologyMolecularFunction	double-stranded RNA binding	HMGB1 ACTN1	1.53e-03	78	15	2	GO:0003725
GeneOntologyMolecularFunction	nucleosome binding	RBBP4 SMARCC2	2.40e-03	98	15	2	GO:0031491
GeneOntologyMolecularFunction	molecular adaptor activity	SMARCC2 HMGB1 ACTN1 STX12 SRCAP	2.42e-03	1356	15	5	GO:0060090
GeneOntologyMolecularFunction	N-acyltransferase activity	NMT1 SRCAP	2.60e-03	102	15	2	GO:0016410
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	RBBP4 SRCAP	3.99e-03	127	15	2	GO:0008094
GeneOntologyMolecularFunction	chromatin DNA binding	RBBP4 SMARCC2	6.80e-03	167	15	2	GO:0031490
GeneOntologyMolecularFunction	integrin binding	HMGB1 ACTN1	7.44e-03	175	15	2	GO:0005178
GeneOntologyMolecularFunction	heparin binding	CRISPLD2 HMGB1	8.89e-03	192	15	2	GO:0008201
GeneOntologyMolecularFunction	lyase activity	HMGB1 TGDS	1.08e-02	212	15	2	GO:0016829
GeneOntologyBiologicalProcess	chromatin remodeling	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	7.99e-06	741	15	6	GO:0006338
GeneOntologyBiologicalProcess	chromatin organization	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	2.36e-05	896	15	6	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	4.36e-05	999	15	6	GO:0071824
GeneOntologyBiologicalProcess	negative regulation of stem cell population maintenance	RBBP4 RBBP7	1.59e-04	26	15	2	GO:1902455
GeneOntologyBiologicalProcess	regulation of nucleotide-excision repair	SMARCC2 HMGB1	1.98e-04	29	15	2	GO:2000819
GeneOntologyBiologicalProcess	regulation of cell fate specification	RBBP4 RBBP7	1.98e-04	29	15	2	GO:0042659
GeneOntologyBiologicalProcess	regulation of transforming growth factor beta receptor signaling pathway	CDKN1C RBBP4 RBBP7	3.33e-04	192	15	3	GO:0017015
GeneOntologyBiologicalProcess	regulation of cellular response to transforming growth factor beta stimulus	CDKN1C RBBP4 RBBP7	3.48e-04	195	15	3	GO:1903844
GeneOntologyBiologicalProcess	positive regulation of stem cell population maintenance	RBBP4 RBBP7	6.17e-04	51	15	2	GO:1902459
GeneOntologyBiologicalProcess	regulation of cell fate commitment	RBBP4 RBBP7	6.66e-04	53	15	2	GO:0010453
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7	6.71e-04	1053	15	5	GO:0000122
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	RBBP4 SMARCC2 RBBP7 SRCAP	5.48e-07	96	15	4	GO:0070603
GeneOntologyCellularComponent	ATPase complex	RBBP4 SMARCC2 RBBP7 SRCAP	1.79e-06	129	15	4	GO:1904949
GeneOntologyCellularComponent	NURF complex	RBBP4 RBBP7	1.01e-05	7	15	2	GO:0016589
GeneOntologyCellularComponent	histone deacetylase complex	RBBP4 RBBP7 SRCAP	2.85e-05	85	15	3	GO:0000118
GeneOntologyCellularComponent	ISWI-type complex	RBBP4 RBBP7	4.35e-05	14	15	2	GO:0031010
GeneOntologyCellularComponent	ESC/E(Z) complex	RBBP4 RBBP7	6.50e-05	17	15	2	GO:0035098
GeneOntologyCellularComponent	NuRD complex	RBBP4 RBBP7	6.50e-05	17	15	2	GO:0016581
GeneOntologyCellularComponent	CHD-type complex	RBBP4 RBBP7	6.50e-05	17	15	2	GO:0090545
GeneOntologyCellularComponent	Sin3-type complex	RBBP4 RBBP7	1.10e-04	22	15	2	GO:0070822
GeneOntologyCellularComponent	PcG protein complex	RBBP4 RBBP7	6.24e-04	52	15	2	GO:0031519
GeneOntologyCellularComponent	nuclear chromosome	RBBP4 RBBP7 SRCAP	7.24e-04	254	15	3	GO:0000228
GeneOntologyCellularComponent	histone methyltransferase complex	RBBP4 RBBP7	1.29e-03	75	15	2	GO:0035097
GeneOntologyCellularComponent	secretory granule lumen	CRISPLD2 HMGB1 ACTN1	1.47e-03	325	15	3	GO:0034774
GeneOntologyCellularComponent	cytoplasmic vesicle lumen	CRISPLD2 HMGB1 ACTN1	1.54e-03	330	15	3	GO:0060205
GeneOntologyCellularComponent	vesicle lumen	CRISPLD2 HMGB1 ACTN1	1.57e-03	332	15	3	GO:0031983
GeneOntologyCellularComponent	methyltransferase complex	RBBP4 RBBP7	2.66e-03	108	15	2	GO:0034708
GeneOntologyCellularComponent	chromosomal region	RBBP4 SMARCC2 RBBP7	3.08e-03	421	15	3	GO:0098687
GeneOntologyCellularComponent	ficolin-1-rich granule lumen	CRISPLD2 HMGB1	3.48e-03	124	15	2	GO:1904813
GeneOntologyCellularComponent	chromosome, telomeric region	RBBP4 RBBP7	6.89e-03	176	15	2	GO:0000781
GeneOntologyCellularComponent	ficolin-1-rich granule	CRISPLD2 HMGB1	7.58e-03	185	15	2	GO:0101002
GeneOntologyCellularComponent	transcription regulator complex	RBBP4 HMGB1 RBBP7	8.12e-03	596	15	3	GO:0005667
GeneOntologyCellularComponent	secretory vesicle	CRISPLD2 HMGB1 ACTN1 STX12	1.01e-02	1246	15	4	GO:0099503
GeneOntologyCellularComponent	nuclear protein-containing complex	RBBP4 SMARCC2 RBBP7 SRCAP	1.42e-02	1377	15	4	GO:0140513
HumanPheno	Short 5th finger	CDKN1C SMARCC2 SRCAP	3.68e-05	64	6	3	HP:0009237
HumanPheno	Aplasia/Hypoplasia of the 5th finger	CDKN1C SMARCC2 SRCAP	4.04e-05	66	6	3	HP:0006262
HumanPheno	Abnormality of the humerus	KIAA0753 TGDS SRCAP	4.42e-05	68	6	3	HP:0003063
HumanPheno	Abnormal 5th finger morphology	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	5.39e-05	509	6	5	HP:0004207
HumanPheno	Abnormality of the upper arm	KIAA0753 TGDS SRCAP	7.49e-05	81	6	3	HP:0001454
HumanPheno	Aplasia/hypoplasia involving bones of the upper limbs	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	9.57e-05	572	6	5	HP:0006496
HumanPheno	Clinodactyly	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	9.73e-05	574	6	5	HP:0030084
HumanPheno	Abnormal epiphysis morphology	CDKN1C KIAA0753 TGDS SRCAP	1.21e-04	279	6	4	HP:0005930
HumanPheno	Abnormal humerus morphology	KIAA0753 SRCAP	1.56e-04	17	6	2	HP:0031095
HumanPheno	Inguinal hernia	CDKN1C SMARCC2 TGDS SRCAP	1.88e-04	312	6	4	HP:0000023
HumanPheno	Brachydactyly	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	2.08e-04	670	6	5	HP:0001156
HumanPheno	Short digit	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	2.11e-04	672	6	5	HP:0011927
HumanPheno	Aplasia involving bones of the extremities	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	3.82e-04	759	6	5	HP:0009825
HumanPheno	Aplasia/hypoplasia involving bones of the extremities	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	3.87e-04	761	6	5	HP:0045060
HumanPheno	Hypospadias	CDKN1C SMARCC2 KIAA0753 SRCAP	3.93e-04	377	6	4	HP:0000047
HumanPheno	Hepatoblastoma	CDKN1C SMARCC2	4.31e-04	28	6	2	HP:0002884
HumanPheno	Cryptorchidism	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	4.36e-04	780	6	5	HP:0000028
HumanPheno	Displacement of the urethral meatus	CDKN1C SMARCC2 KIAA0753 SRCAP	4.80e-04	397	6	4	HP:0100627
HumanPheno	Abnormal male urethral meatus morphology	CDKN1C SMARCC2 KIAA0753 SRCAP	4.90e-04	399	6	4	HP:0032076
HumanPheno	Aplasia/hypoplasia of the extremities	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	5.34e-04	813	6	5	HP:0009815
HumanPheno	Broad nasal tip	SMARCC2 KIAA0753 SRCAP	5.57e-04	159	6	3	HP:0000455
HumanPheno	Short humerus	KIAA0753 TGDS	5.65e-04	32	6	2	HP:0005792
HumanPheno	Abnormal anatomic location of the heart	KIAA0753 TGDS SRCAP	5.67e-04	160	6	3	HP:0004307
HumanPheno	Aplasia/hypoplasia of the humerus	KIAA0753 TGDS	6.01e-04	33	6	2	HP:0006507
HumanPheno	Limb undergrowth	CDKN1C KIAA0753 TGDS SRCAP	7.41e-04	444	6	4	HP:0009826
HumanPheno	Finger clinodactyly	CDKN1C KIAA0753 TGDS SRCAP	7.94e-04	452	6	4	HP:0040019
HumanPheno	Abnormality of the urethra	CDKN1C SMARCC2 KIAA0753 SRCAP	8.86e-04	465	6	4	HP:0000795
HumanPheno	Abnormal 2nd finger morphology	TGDS SRCAP	1.02e-03	43	6	2	HP:0004100
HumanPheno	Hernia of the abdominal wall	CDKN1C SMARCC2 TGDS SRCAP	1.23e-03	506	6	4	HP:0004299
HumanPheno	Abdominal wall defect	CDKN1C SMARCC2 TGDS SRCAP	1.27e-03	511	6	4	HP:0010866
HumanPheno	Thoracoabdominal wall defect	CDKN1C SMARCC2 TGDS SRCAP	1.27e-03	511	6	4	HP:0100656
HumanPheno	Deviation of finger	CDKN1C KIAA0753 TGDS SRCAP	1.54e-03	537	6	4	HP:0004097
HumanPheno	Aplasia/hypoplasia involving bones of the hand	CDKN1C SMARCC2 TGDS SRCAP	1.55e-03	538	6	4	HP:0005927
HumanPheno	Hypoplastic fingernail	CDKN1C SMARCC2	1.55e-03	53	6	2	HP:0001804
HumanPheno	Abnormality of the metacarpal bones	KIAA0753 TGDS SRCAP	1.60e-03	228	6	3	HP:0001163
HumanPheno	Abnormal metacarpal morphology	KIAA0753 TGDS SRCAP	1.60e-03	228	6	3	HP:0005916
HumanPheno	Abnormality of the abdominal wall	CDKN1C SMARCC2 TGDS SRCAP	1.81e-03	560	6	4	HP:0004298
HumanPheno	Deviation of the hand or of fingers of the hand	CDKN1C KIAA0753 TGDS SRCAP	1.86e-03	564	6	4	HP:0009484
HumanPheno	Abnormal nostril morphology	SMARCC2 KIAA0753 TGDS SRCAP	2.00e-03	575	6	4	HP:0005288
HumanPheno	Abnormal hand morphology	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	2.12e-03	1082	6	5	HP:0005922
HumanPheno	Hernia	CDKN1C SMARCC2 TGDS SRCAP	2.19e-03	589	6	4	HP:0100790
HumanPheno	Postnatal growth retardation	CDKN1C SMARCC2 TGDS	2.29e-03	258	6	3	HP:0008897
HumanPheno	Prominent forehead	CDKN1C KIAA0753 SRCAP	2.37e-03	261	6	3	HP:0011220
HumanPheno	Hydronephrosis	CDKN1C KIAA0753 SRCAP	2.45e-03	264	6	3	HP:0000126
HumanPheno	Abnormal testis morphology	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	2.60e-03	1129	6	5	HP:0000035
HumanPheno	Prominent metopic ridge	CDKN1C SRCAP	2.62e-03	69	6	2	HP:0005487
HumanPheno	Non-obstructive azoospermia	CDKN1C SMARCC2 KIAA0753 TGDS SRCAP	2.63e-03	1132	6	5	HP:0011961
Domain	CAF1C_H4-bd	RBBP4 RBBP7	1.34e-06	3	13	2	PF12265
Domain	Histone-bd_RBBP4_N	RBBP4 RBBP7	1.34e-06	3	13	2	IPR022052
Domain	G-protein_beta_WD-40_rep	RBBP4 RBBP7	1.55e-03	85	13	2	IPR020472
Domain	WD40_repeat_CS	RBBP4 RBBP7	5.61e-03	164	13	2	IPR019775
Domain	WD40	RBBP4 RBBP7	1.35e-02	259	13	2	PF00400
Domain	WD40	RBBP4 RBBP7	1.44e-02	268	13	2	SM00320
Domain	WD40_repeat	RBBP4 RBBP7	1.48e-02	272	13	2	IPR001680
Domain	WD_REPEATS_1	RBBP4 RBBP7	1.55e-02	278	13	2	PS00678
Domain	WD_REPEATS_2	RBBP4 RBBP7	1.56e-02	279	13	2	PS50082
Domain	WD_REPEATS_REGION	RBBP4 RBBP7	1.56e-02	279	13	2	PS50294
Domain	WD40_repeat_dom	RBBP4 RBBP7	1.75e-02	297	13	2	IPR017986
Domain	-	RBBP4 RBBP7	2.17e-02	333	13	2	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	RBBP4 RBBP7	2.20e-02	335	13	2	IPR015943
Pathway	BIOCARTA_PRC2_PATHWAY	RBBP4 RBBP7	4.30e-05	11	13	2	MM1548
Pathway	WP_RETINOBLASTOMA_GENE_IN_CANCER	RBBP4 HMGB1 RBBP7	6.87e-05	90	13	3	M39678
Pathway	BIOCARTA_PRC2_PATHWAY	RBBP4 RBBP7	7.10e-05	14	13	2	M22025
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	RBBP4 SMARCC2 RBBP7	8.59e-05	97	13	3	M48262
Pathway	WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2	RBBP4 RBBP7	9.35e-05	16	13	2	M39484
Pathway	REACTOME_APOPTOSIS	NMT1 TNFSF10 HMGB1	1.18e-04	108	13	3	MM14471
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119	RBBP4 RBBP7	1.79e-04	22	13	2	M47924
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6	RBBP4 RBBP7	2.33e-04	25	13	2	MM15546
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	RBBP4 SMARCC2 RBBP7	2.66e-04	142	13	3	M48257
Pathway	REACTOME_PROGRAMMED_CELL_DEATH	NMT1 TNFSF10 HMGB1	2.66e-04	142	13	3	MM15178
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	RBBP4 RBBP7	2.72e-04	27	13	2	MM15537
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES	RBBP4 RBBP7	2.72e-04	27	13	2	M47941
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	RBBP4 RBBP7	3.14e-04	29	13	2	MM15340
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	RBBP4 RBBP7	3.37e-04	30	13	2	M27637
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	RBBP4 IGKV5-2 RBBP7	3.37e-04	154	13	3	M39007
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	RBBP4 RBBP7	3.60e-04	31	13	2	M48258
Pathway	WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1	RBBP4 SMARCC2	3.60e-04	31	13	2	M39522
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6	RBBP4 RBBP7	4.33e-04	34	13	2	M27826
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	RBBP4 SMARCC2 RBBP7	4.91e-04	175	13	3	MM14941
Pathway	WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA	RBBP4 RBBP7	5.13e-04	37	13	2	M39756
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	RBBP4 RBBP7	5.13e-04	37	13	2	MM14899
Pathway	REACTOME_APOPTOSIS	NMT1 TNFSF10 HMGB1	5.24e-04	179	13	3	M15303
Pathway	REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA	RBBP4 RBBP7	5.71e-04	39	13	2	MM14850
Pathway	REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	SMARCC2 RBBP7	6.00e-04	40	13	2	MM14936
Pathway	KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119	RBBP4 RBBP7	6.00e-04	40	13	2	M47917
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	RBBP4 RBBP7	7.94e-04	46	13	2	MM14933
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	RBBP4 RBBP7	8.29e-04	47	13	2	MM15428
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	RBBP4 RBBP7	8.29e-04	47	13	2	M1095
Pathway	REACTOME_PROGRAMMED_CELL_DEATH	NMT1 TNFSF10 HMGB1	8.46e-04	211	13	3	M27436
Pathway	PID_HEDGEHOG_GLI_PATHWAY	RBBP4 RBBP7	8.65e-04	48	13	2	M219
Pathway	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	RBBP4 RBBP7	9.38e-04	50	13	2	MM15308
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	RBBP4 RBBP7	1.13e-03	55	13	2	MM14932
Pathway	REACTOME_REGULATED_NECROSIS	TNFSF10 HMGB1	1.30e-03	59	13	2	M41803
Pathway	REACTOME_REGULATED_NECROSIS	TNFSF10 HMGB1	1.30e-03	59	13	2	MM15169
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	RBBP4 RBBP7	1.39e-03	61	13	2	M27811
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	RBBP4 SMARCC2 RBBP7	1.45e-03	254	13	3	M27131
Pathway	PID_HDAC_CLASSI_PATHWAY	RBBP4 RBBP7	1.63e-03	66	13	2	M101
Pathway	PID_TELOMERASE_PATHWAY	RBBP4 RBBP7	1.68e-03	67	13	2	M105
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	RBBP4 SMARCC2 RBBP7	1.76e-03	272	13	3	M29619
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	RBBP4 RBBP7	1.83e-03	70	13	2	M27231
Pathway	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	RBBP4 RBBP7	1.93e-03	72	13	2	M29714
Pathway	REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA	RBBP4 RBBP7	1.93e-03	72	13	2	M27132
Pathway	REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION	RBBP4 RBBP7	2.10e-03	75	13	2	M27343
Pathway	REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	SMARCC2 RBBP7	2.27e-03	78	13	2	M27234
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	RBBP4 RBBP7	2.50e-03	82	13	2	M2
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	RBBP4 RBBP7	3.27e-03	94	13	2	M27230
Pathway	REACTOME_PTEN_REGULATION	RBBP4 RBBP7	3.55e-03	98	13	2	MM15348
Pathway	REACTOME_CHROMOSOME_MAINTENANCE	RBBP4 RBBP7	3.84e-03	102	13	2	MM15430
Pathway	REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH	RBBP4 RBBP7	3.99e-03	104	13	2	M29829
Pathway	REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	RBBP4 RBBP7	4.06e-03	105	13	2	M27425
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS	RBBP4 RBBP7	4.22e-03	107	13	2	M48260
Pathway	REACTOME_ADIPOGENESIS	RBBP4 RBBP7	4.45e-03	110	13	2	M48259
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	RBBP4 RBBP7	4.45e-03	110	13	2	M27696
Pathway	WP_COMPREHENSIVE_IL17A_SIGNALING	RBBP4 HMGB1	4.45e-03	110	13	2	MM16642
Pathway	REACTOME_CELLULAR_SENESCENCE	RBBP4 RBBP7	5.19e-03	119	13	2	MM14901
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	RBBP4 RBBP7	5.44e-03	122	13	2	M29689
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	RBBP4 RBBP7	5.71e-03	125	13	2	M27186
Pathway	REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	CDKN1C RBBP4	6.16e-03	130	13	2	MM15146
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	RBBP4 RBBP7	6.72e-03	136	13	2	MM14848
Pathway	REACTOME_HCMV_EARLY_EVENTS	RBBP4 RBBP7	6.91e-03	138	13	2	M29805
Pathway	REACTOME_PTEN_REGULATION	RBBP4 RBBP7	7.01e-03	139	13	2	M27646
Pathway	REACTOME_CHROMOSOME_MAINTENANCE	RBBP4 RBBP7	7.01e-03	139	13	2	M868
Pathway	REACTOME_VIRAL_INFECTION_PATHWAYS	NMT1 RBBP4 IGKV5-2 RBBP7	7.07e-03	888	13	4	M48034
Pathway	REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	CDKN1C RBBP4	8.02e-03	149	13	2	M848
Pathway	REACTOME_SARS_COV_INFECTIONS	RBBP4 IGKV5-2 RBBP7	8.25e-03	471	13	3	M39009
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	RBBP4 RBBP7	8.87e-03	157	13	2	MM15226
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	RBBP4 RBBP7	9.20e-03	160	13	2	M27498
Pathway	REACTOME_HCMV_INFECTION	RBBP4 RBBP7	9.42e-03	162	13	2	M29804
Pathway	REACTOME_CELLULAR_SENESCENCE	RBBP4 RBBP7	1.37e-02	197	13	2	M27188
Pathway	REACTOME_INFECTIOUS_DISEASE	NMT1 RBBP4 IGKV5-2 RBBP7	1.40e-02	1081	13	4	M27548
Pubmed	A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.	RBBP4 SMARCC2 SRCAP	3.62e-08	16	15	3	11013263
Pubmed	Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).	RBBP4 SMARCC2 RBBP7	3.62e-08	16	15	3	11784859
Pubmed	ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.	RBBP4 SMARCC2 RBBP7	8.59e-08	21	15	3	12453419
Pubmed	TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.	RBBP4 SMARCC2 RBBP7	9.95e-08	22	15	3	17803295
Pubmed	Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).	RBBP4 RBBP7	1.74e-07	2	15	2	38577935
Pubmed	Overlapping functions of RBBP4 and RBBP7 in regulating cell proliferation and histone H3.3 deposition during mouse preimplantation development.	RBBP4 RBBP7	1.74e-07	2	15	2	34709113
Pubmed	Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy.	TNFSF10 HMGB1	1.74e-07	2	15	2	25607248
Pubmed	Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes.	RBBP4 RBBP7	1.74e-07	2	15	2	12376095
Pubmed	HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.	TNFSF10 HMGB1	1.74e-07	2	15	2	26871575
Pubmed	The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor alpha mediated gene expression.	RBBP4 RBBP7	5.21e-07	3	15	2	18577416
Pubmed	Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast.	RBBP4 RBBP7	5.21e-07	3	15	2	7503932
Pubmed	HMGB1 induced inflammatory effect is blocked by CRISPLD2 via MiR155 in hepatic fibrogenesis.	CRISPLD2 HMGB1	5.21e-07	3	15	2	26624800
Pubmed	The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4/7.	RBBP4 RBBP7	5.21e-07	3	15	2	27144666
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	RBBP4 SMARCC2 RBBP7	7.38e-07	42	15	3	16387653
Pubmed	Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB.	RBBP4 RBBP7	1.04e-06	4	15	2	10866654
Pubmed	Isolation of human NURF: a regulator of Engrailed gene expression.	RBBP4 RBBP7	1.04e-06	4	15	2	14609955
Pubmed	Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.	RBBP4 RBBP7	1.04e-06	4	15	2	24727455
Pubmed	Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners.	RBBP4 SMARCC2 RBBP7	1.18e-06	49	15	3	19759913
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	RBBP4 SMARCC2 RBBP7	1.50e-06	53	15	3	21532573
Pubmed	Mrg15 stimulates Ash1 H3K36 methyltransferase activity and facilitates Ash1 Trithorax group protein function in Drosophila.	RBBP4 RBBP7	1.73e-06	5	15	2	29158494
Pubmed	MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.	RBBP4 RBBP7	1.73e-06	5	15	2	10471499
Pubmed	Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases.	RBBP4 RBBP7	2.60e-06	6	15	2	11788710
Pubmed	SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex.	RBBP4 RBBP7	2.60e-06	6	15	2	16738318
Pubmed	Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase.	RBBP4 RBBP7	2.60e-06	6	15	2	9427644
Pubmed	The structure of the core NuRD repression complex provides insights into its interaction with chromatin.	RBBP4 RBBP7	2.60e-06	6	15	2	27098840
Pubmed	CRL4(RBBP7) is required for efficient CENP-A deposition at centromeres.	RBBP4 RBBP7	2.60e-06	6	15	2	25795299
Pubmed	Expression, purification and characterization of the human MTA2-RBBP7 complex.	RBBP4 RBBP7	2.60e-06	6	15	2	28179136
Pubmed	BRCA1 interacts with components of the histone deacetylase complex.	RBBP4 RBBP7	2.60e-06	6	15	2	10220405
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	RBBP4 RBBP7 SRCAP	3.34e-06	69	15	3	28481362
Pubmed	Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex.	RBBP4 RBBP7	3.64e-06	7	15	2	19686092
Pubmed	Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2.	RBBP4 RBBP7	3.64e-06	7	15	2	14612411
Pubmed	CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.	RBBP4 RBBP7	3.64e-06	7	15	2	20523938
Pubmed	Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.	RBBP4 RBBP7	3.64e-06	7	15	2	12435631
Pubmed	Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	RBBP4 HMGB1 RBBP7 ACTN1	3.85e-06	259	15	4	31162944
Pubmed	Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex.	RBBP4 RBBP7	4.85e-06	8	15	2	18182442
Pubmed	Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation.	RBBP4 RBBP7	4.85e-06	8	15	2	20144788
Pubmed	The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.	RBBP4 RBBP7	4.85e-06	8	15	2	11297506
Pubmed	Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex.	RBBP4 RBBP7	4.85e-06	8	15	2	11118440
Pubmed	Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.	RBBP4 RBBP7	4.85e-06	8	15	2	10471500
Pubmed	MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.	RBBP4 RBBP7	4.85e-06	8	15	2	12705869
Pubmed	The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex.	RBBP4 RBBP7	4.85e-06	8	15	2	18067919
Pubmed	Identification and functional characterization of the p66/p68 components of the MeCP1 complex.	RBBP4 RBBP7	6.24e-06	9	15	2	11756549
Pubmed	RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest.	RBBP4 RBBP7	6.24e-06	9	15	2	11283269
Pubmed	Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex.	RBBP4 RBBP7	6.24e-06	9	15	2	9150135
Pubmed	Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity.	RBBP4 RBBP7	6.24e-06	9	15	2	23104054
Pubmed	RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.	RBBP4 RBBP7	6.24e-06	9	15	2	22926524
Pubmed	Identification of a nuclear domain with deacetylase activity.	RBBP4 RBBP7	6.24e-06	9	15	2	10984530
Pubmed	JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.	RBBP4 RBBP7	6.24e-06	9	15	2	20075857
Pubmed	Proteomic analysis of the SIRT6 interactome: novel links to genome maintenance and cellular stress signaling.	RBBP4 RBBP7 ACTN1	6.73e-06	87	15	3	24169447
Pubmed	ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis.	RBBP4 RBBP7	7.80e-06	10	15	2	19644445
Pubmed	Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes.	RBBP4 RBBP7	7.80e-06	10	15	2	20388487
Pubmed	PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex.	RBBP4 RBBP7	7.80e-06	10	15	2	34180153
Pubmed	Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.	RBBP4 SMARCC2	7.80e-06	10	15	2	11238380
Pubmed	Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.	RBBP4 RBBP7	7.80e-06	10	15	2	15451426
Pubmed	Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress.	RBBP4 RBBP7	7.80e-06	10	15	2	20127688
Pubmed	BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.	RBBP4 RBBP7	7.80e-06	10	15	2	16091750
Pubmed	EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells.	RBBP4 RBBP7	7.80e-06	10	15	2	31451685
Pubmed	Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes.	RBBP4 RBBP7	9.53e-06	11	15	2	29263092
Pubmed	MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.	RBBP4 RBBP7	9.53e-06	11	15	2	15456747
Pubmed	Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal.	RBBP4 RBBP7	9.53e-06	11	15	2	22438827
Pubmed	The program for processing newly synthesized histones H3.1 and H4.	RBBP4 RBBP7	9.53e-06	11	15	2	20953179
Pubmed	An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.	RBBP4 RBBP7	9.53e-06	11	15	2	23273982
Pubmed	Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription.	RBBP4 RBBP7	9.53e-06	11	15	2	14581478
Pubmed	USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair.	RBBP4 RBBP7	1.14e-05	12	15	2	31504778
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	RBBP4 RBBP7	1.14e-05	12	15	2	22560079
Pubmed	The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.	RBBP4 RBBP7	1.14e-05	12	15	2	23708667
Pubmed	Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.	RBBP4 RBBP7	1.14e-05	12	15	2	21937684
Pubmed	NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.	RBBP4 RBBP7	1.14e-05	12	15	2	9885572
Pubmed	The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.	RBBP4 RBBP7	1.35e-05	13	15	2	12124384
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	RBBP4 RBBP7	1.35e-05	13	15	2	19703393
Pubmed	The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.	RBBP4 RBBP7	1.35e-05	13	15	2	12920132
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	RBBP4 RBBP7	1.58e-05	14	15	2	16428440
Pubmed	Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.	RBBP4 RBBP7	1.58e-05	14	15	2	26201719
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	RBBP4 RBBP7	1.58e-05	14	15	2	25150861
Pubmed	GATA-1 forms distinct activating and repressive complexes in erythroid cells.	RBBP4 RBBP7	1.58e-05	14	15	2	15920471
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	NMT1 SMARCC2 HMGB1 ACTN1 SRCAP	1.64e-05	807	15	5	30575818
Pubmed	Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.	RBBP4 RBBP7	1.82e-05	15	15	2	30135474
Pubmed	Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.	RBBP4 RBBP7	1.82e-05	15	15	2	9804427
Pubmed	DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression.	RBBP4 RBBP7	1.82e-05	15	15	2	35695185
Pubmed	Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply.	RBBP4 RBBP7	1.82e-05	15	15	2	22407294
Pubmed	NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.	RBBP4 RBBP7	1.82e-05	15	15	2	19927129
Pubmed	The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.	RBBP4 RBBP7	1.82e-05	15	15	2	25247294
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	RBBP4 RBBP7	1.82e-05	15	15	2	15701600
Pubmed	Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.	RBBP4 HMGB1 RBBP7	1.90e-05	123	15	3	35583604
Pubmed	RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation.	RBBP4 RBBP7	2.08e-05	16	15	2	30760870
Pubmed	Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1.	RBBP4 RBBP7	2.08e-05	16	15	2	11102443
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	RBBP4 SMARCC2 HMGB1 RBBP7	2.11e-05	399	15	4	35987950
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	SMARCC2 HMGB1 RBBP7	2.30e-05	131	15	3	34551306
Pubmed	Examining post-translational modification-mediated protein-protein interactions using a chemical proteomics approach.	RBBP4 RBBP7	2.35e-05	17	15	2	23281010
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	SMARCC2 HMGB1 RBBP7 ACTN1	2.37e-05	411	15	4	36652389
Pubmed	USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier.	RBBP4 RBBP7	2.65e-05	18	15	2	17846119
Pubmed	Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.	RBBP4 RBBP7	2.65e-05	18	15	2	10444591
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	RBBP4 RBBP7	2.65e-05	18	15	2	9790534
Pubmed	Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region.	RBBP4 SMARCC2	2.65e-05	18	15	2	16217013
Pubmed	A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.	RBBP4 RBBP7	2.65e-05	18	15	2	12493763
Pubmed	Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.	RBBP4 RBBP7	2.65e-05	18	15	2	20064376
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	RBBP4 SMARCC2	2.65e-05	18	15	2	28068325
Pubmed	Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis.	RBBP4 RBBP7	2.65e-05	18	15	2	14645126
Pubmed	Human family with sequence similarity 60 member A (FAM60A) protein: a new subunit of the Sin3 deacetylase complex.	RBBP4 RBBP7	2.96e-05	19	15	2	22984288
Pubmed	Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal.	RBBP4 RBBP7	2.96e-05	19	15	2	28554894
Interaction	TAF6 interactions	NMT1 RBBP4 SMARCC2 RBBP7 ACTN1	4.67e-07	245	14	5	int:TAF6
Interaction	ZNF827 interactions	RBBP4 HMGB1 RBBP7	9.65e-07	29	14	3	int:ZNF827
Interaction	CREBBP interactions	TNFSF10 RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	1.65e-06	599	14	6	int:CREBBP
Interaction	PHF23 interactions	RBBP4 HMGB1 RBBP7	2.80e-06	41	14	3	int:PHF23
Interaction	H2AZ1 interactions	RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	3.59e-06	371	14	5	int:H2AZ1
Interaction	H3-3A interactions	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	6.01e-06	749	14	6	int:H3-3A
Interaction	NEUROD6 interactions	CDKN1C HMGB1	6.71e-06	6	14	2	int:NEUROD6
Interaction	SMARCA1 interactions	RBBP4 SMARCC2 HMGB1 RBBP7	6.82e-06	188	14	4	int:SMARCA1
Interaction	SMARCA4 interactions	RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	1.05e-05	462	14	5	int:SMARCA4
Interaction	ING2 interactions	RBBP4 SMARCC2 RBBP7	1.30e-05	68	14	3	int:ING2
Interaction	H3C1 interactions	CDKN1C RBBP4 SMARCC2 HMGB1 RBBP7 SRCAP	1.73e-05	901	14	6	int:H3C1
Interaction	ASF1A interactions	RBBP4 SMARCC2 RBBP7 SRCAP	2.07e-05	249	14	4	int:ASF1A
Interaction	ZNF219 interactions	RBBP4 RBBP7 STX12	3.03e-05	90	14	3	int:ZNF219
Interaction	ARID1A interactions	RBBP4 SMARCC2 RBBP7 ACTN1	3.09e-05	276	14	4	int:ARID1A
Interaction	NKX3-2 interactions	RBBP4 RBBP7	3.48e-05	13	14	2	int:NKX3-2
Interaction	MRE11 interactions	NMT1 RBBP4 SMARCC2 HMGB1	3.60e-05	287	14	4	int:MRE11
Interaction	TOPORS interactions	RBBP4 SMARCC2 RBBP7	3.67e-05	96	14	3	int:TOPORS
Interaction	ACTL6A interactions	RBBP4 SMARCC2 RBBP7 SRCAP	3.70e-05	289	14	4	int:ACTL6A
Interaction	KDM5B interactions	RBBP4 SMARCC2 RBBP7	4.15e-05	100	14	3	int:KDM5B
Interaction	FLII interactions	NMT1 RBBP4 SMARCC2 RBBP7	4.17e-05	298	14	4	int:FLII
Interaction	ING1 interactions	RBBP4 SMARCC2 RBBP7	4.53e-05	103	14	3	int:ING1
Interaction	SIRT6 interactions	RBBP4 SMARCC2 RBBP7 ACTN1 SRCAP	4.58e-05	628	14	5	int:SIRT6
Interaction	MTF2 interactions	RBBP4 RBBP7 TGDS	6.80e-05	118	14	3	int:MTF2
Interaction	PWWP2B interactions	RBBP4 RBBP7	6.81e-05	18	14	2	int:PWWP2B
Interaction	SMARCA2 interactions	RBBP4 SMARCC2 HMGB1 RBBP7	7.46e-05	346	14	4	int:SMARCA2
Interaction	SMARCC2 interactions	RBBP4 SMARCC2 RBBP7 SRCAP	8.06e-05	353	14	4	int:SMARCC2
Interaction	SMARCB1 interactions	RBBP4 SMARCC2 RBBP7 SRCAP	9.08e-05	364	14	4	int:SMARCB1
Interaction	SP1 interactions	TNFSF10 RBBP4 SMARCC2 RBBP7	9.18e-05	365	14	4	int:SP1
Interaction	FNBP1 interactions	RBBP4 SMARCC2 RBBP7	9.27e-05	131	14	3	int:FNBP1
Interaction	ZFPM1 interactions	RBBP4 RBBP7	1.03e-04	22	14	2	int:ZFPM1
Interaction	WDR76 interactions	RBBP4 SMARCC2 HMGB1 RBBP7	1.11e-04	383	14	4	int:WDR76
Interaction	SMARCC1 interactions	RBBP4 SMARCC2 RBBP7 SRCAP	1.12e-04	384	14	4	int:SMARCC1
Interaction	RB1 interactions	CDKN1C RBBP4 HMGB1 RBBP7	1.23e-04	394	14	4	int:RB1
Interaction	H2AC18 interactions	RBBP4 SMARCC2 HMGB1	1.33e-04	148	14	3	int:H2AC18
Interaction	SMARCA5 interactions	RBBP4 SMARCC2 HMGB1 RBBP7	1.51e-04	415	14	4	int:SMARCA5
Interaction	BAZ1A interactions	RBBP4 SMARCC2 RBBP7	1.56e-04	156	14	3	int:BAZ1A
Interaction	HMGA1 interactions	RBBP4 HMGB1 RBBP7 SRCAP	1.56e-04	419	14	4	int:HMGA1
Interaction	ZFPM2 interactions	RBBP4 RBBP7	1.68e-04	28	14	2	int:ZFPM2
Interaction	MBD2 interactions	RBBP4 SMARCC2 RBBP7	1.71e-04	161	14	3	int:MBD2
Interaction	HIRA interactions	RBBP4 SMARCC2 RBBP7	1.84e-04	165	14	3	int:HIRA
Interaction	SAP30 interactions	RBBP4 SMARCC2 RBBP7	1.90e-04	167	14	3	int:SAP30
Interaction	GATA1 interactions	RBBP4 SMARCC2 RBBP7	2.04e-04	171	14	3	int:GATA1
Interaction	ZNF296 interactions	RBBP4 RBBP7	2.06e-04	31	14	2	int:ZNF296
Interaction	CPSF2 interactions	RBBP4 SMARCC2 RBBP7	2.11e-04	173	14	3	int:CPSF2
Interaction	KPNA6 interactions	RBBP4 HMGB1 RBBP7	2.15e-04	174	14	3	int:KPNA6
Interaction	SAP30L interactions	RBBP4 RBBP7	2.34e-04	33	14	2	int:SAP30L
Interaction	CDAN1 interactions	RBBP7 ACTN1	2.48e-04	34	14	2	int:CDAN1
Interaction	BAHCC1 interactions	RBBP4 RBBP7	2.63e-04	35	14	2	int:BAHCC1
Interaction	TGIF2LX interactions	RBBP4 RBBP7	2.79e-04	36	14	2	int:TGIF2LX
Interaction	TBC1D2 interactions	RBBP4 RBBP7	2.94e-04	37	14	2	int:TBC1D2
Interaction	MYOD1 interactions	CDKN1C MSANTD2 SMARCC2	2.96e-04	194	14	3	int:MYOD1
Interaction	AGR2 interactions	NMT1 SMARCC2 HMGB1 ACTN1 SRCAP	2.98e-04	934	14	5	int:AGR2
Interaction	H3C10 interactions	RBBP4 RBBP7	3.11e-04	38	14	2	int:H3C10
Interaction	ARID4B interactions	RBBP4 SMARCC2 RBBP7	3.19e-04	199	14	3	int:ARID4B
Interaction	EAF2 interactions	RBBP4 RBBP7	3.27e-04	39	14	2	int:EAF2
Interaction	CSNK2A1 interactions	NMT1 RBBP4 SMARCC2 HMGB1 RBBP7	3.32e-04	956	14	5	int:CSNK2A1
Interaction	BANF1 interactions	RBBP4 SMARCC2 RBBP7	3.43e-04	204	14	3	int:BANF1
Interaction	NASP interactions	RBBP4 HMGB1 RBBP7	3.58e-04	207	14	3	int:NASP
Interaction	ZNF521 interactions	RBBP4 RBBP7	3.62e-04	41	14	2	int:ZNF521
Interaction	MBD3L2 interactions	RBBP4 RBBP7	3.62e-04	41	14	2	int:MBD3L2
Interaction	RBP1 interactions	RBBP4 RBBP7	3.80e-04	42	14	2	int:RBP1
Interaction	DUX4 interactions	HMGB1 RBBP7 ACTN1	3.94e-04	214	14	3	int:DUX4
Interaction	H3C12 interactions	RBBP4 RBBP7	3.98e-04	43	14	2	int:H3C12
Interaction	ITFG1 interactions	RBBP4 SMARCC2 RBBP7 STX12	4.12e-04	540	14	4	int:ITFG1
Interaction	NUCKS1 interactions	RBBP4 RBBP7 SRCAP	4.27e-04	220	14	3	int:NUCKS1
Interaction	GATAD2A interactions	RBBP4 SMARCC2 RBBP7	4.51e-04	224	14	3	int:GATAD2A
Interaction	SYMPK interactions	RBBP4 SMARCC2 RBBP7	4.56e-04	225	14	3	int:SYMPK
Interaction	H3C6 interactions	RBBP4 SMARCC2 RBBP7	4.62e-04	226	14	3	int:H3C6
Interaction	NFIX interactions	MSANTD2 SMARCC2 SRCAP	4.68e-04	227	14	3	int:NFIX
Interaction	FOXC1 interactions	SMARCC2 HMGB1 RBBP7	4.74e-04	228	14	3	int:FOXC1
Interaction	ATXN1 interactions	NMT1 RBBP4 SMARCC2 HMGB1 RBBP7	4.89e-04	1039	14	5	int:ATXN1
Interaction	NACC2 interactions	RBBP4 RBBP7	4.96e-04	48	14	2	int:NACC2
Interaction	CDK2AP2 interactions	RBBP4 RBBP7	5.17e-04	49	14	2	int:CDK2AP2
Interaction	RUVBL1 interactions	RBBP4 SMARCC2 RBBP7 SRCAP	5.23e-04	575	14	4	int:RUVBL1
Interaction	H4C3 interactions	RBBP4 RBBP7	5.39e-04	50	14	2	int:H4C3
Interaction	AEBP2 interactions	RBBP4 RBBP7	5.39e-04	50	14	2	int:AEBP2
Interaction	SAFB interactions	RBBP4 HMGB1 RBBP7	5.78e-04	244	14	3	int:SAFB
Interaction	EPOP interactions	RBBP4 RBBP7	5.83e-04	52	14	2	int:EPOP
Interaction	USP43 interactions	RBBP4 RBBP7	5.83e-04	52	14	2	int:USP43
Interaction	GATAD2B interactions	RBBP4 SMARCC2 RBBP7	5.85e-04	245	14	3	int:GATAD2B
Interaction	YAP1 interactions	RBBP4 SMARCC2 RBBP7 ACTN1 SRCAP	6.22e-04	1095	14	5	int:YAP1
Interaction	H4C2 interactions	RBBP4 RBBP7	6.28e-04	54	14	2	int:H4C2
Interaction	JARID2 interactions	RBBP4 RBBP7	6.28e-04	54	14	2	int:JARID2
Interaction	WDR5 interactions	NMT1 RBBP4 SMARCC2 HMGB1 RBBP7	6.38e-04	1101	14	5	int:WDR5
Interaction	DNMT1 interactions	RBBP4 HMGB1 RBBP7	6.50e-04	254	14	3	int:DNMT1
Interaction	SPANXN4 interactions	RBBP4 RBBP7	6.52e-04	55	14	2	int:SPANXN4
Interaction	HDAC1 interactions	TNFSF10 RBBP4 SMARCC2 HMGB1 RBBP7	6.57e-04	1108	14	5	int:HDAC1
Interaction	FN3KRP interactions	RBBP4 RBBP7	7.24e-04	58	14	2	int:FN3KRP
Interaction	H4C13 interactions	RBBP4 RBBP7	7.24e-04	58	14	2	int:H4C13
Interaction	ASH2L interactions	RBBP4 RBBP7 SRCAP	7.35e-04	265	14	3	int:ASH2L
Interaction	ASH1L interactions	RBBP4 RBBP7	7.50e-04	59	14	2	int:ASH1L
Interaction	ATP6V1A interactions	RBBP4 ACTN1 STX12	7.76e-04	270	14	3	int:ATP6V1A
Interaction	ZMYM2 interactions	MSANTD2 RBBP4 RBBP7	7.84e-04	271	14	3	int:ZMYM2
Interaction	ATG16L1 interactions	RBBP4 SMARCC2 RBBP7 STX12 KIAA0753	8.13e-04	1161	14	5	int:ATG16L1
Interaction	ACTR8 interactions	RBBP7 SRCAP	8.27e-04	62	14	2	int:ACTR8
Interaction	NPAT interactions	RBBP4 RBBP7	8.81e-04	64	14	2	int:NPAT
Interaction	MTA1 interactions	RBBP4 SMARCC2 RBBP7	8.89e-04	283	14	3	int:MTA1
Interaction	RBBP5 interactions	RBBP4 SMARCC2 RBBP7	9.26e-04	287	14	3	int:RBBP5
Interaction	SMARCE1 interactions	RBBP4 SMARCC2 HMGB1	9.26e-04	287	14	3	int:SMARCE1
Interaction	IKZF1 interactions	RBBP4 HMGB1 RBBP7	9.35e-04	288	14	3	int:IKZF1
Cytoband	Ensembl 112 genes in cytogenetic band chr1p35	RBBP4 STX12	9.05e-04	137	15	2	chr1p35
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	RBBP4 RBBP7	5.04e-06	6	11	2	1347
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	1.21e-05	9	11	2	1306
GeneFamily	PHD finger proteins\|NuRD complex	RBBP4 RBBP7	2.21e-05	12	11	2	1305
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	2.21e-05	12	11	2	1243
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MSANTD2 SMARCC2	4.56e-04	53	11	2	532
GeneFamily	WD repeat domain containing	RBBP4 RBBP7	1.06e-02	262	11	2	362
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	CRISPLD2 MSANTD2 RBBP4 SRCAP	4.66e-05	323	14	4	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDKN1C CRISPLD2 ACTN1	3.40e-05	193	15	3	7631bf3362b4fa061ffeab4879ab12c4708dc4c0
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDKN1C CRISPLD2 ACTN1	3.40e-05	193	15	3	8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDKN1C CRISPLD2 ACTN1	3.51e-05	195	15	3	8a04f0e92d10a368ccda5f566ae67ef51f1d34a9
ToppCell	MNPs-Monocytes\|MNPs / lung cells shred on cell class, cell subclass, sample id	CDKN1C CRISPLD2 TNFSF10	3.51e-05	195	15	3	45e8d27287bdfd07d7e944ae5d3f44d05c33468f
ToppCell	LAM-Myeloid-Monocyte\|Myeloid / Condition, Lineage and Cell class	CDKN1C CRISPLD2 TNFSF10	3.56e-05	196	15	3	8165e0b5953b3639a56ebe96bb020ae52b7dbd89
ToppCell	severe-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CRISPLD2 TNFSF10 ACTN1	3.62e-05	197	15	3	3b71e523d8a68f131def17233385df371db70db5
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRISPLD2 RBBP7 ACTN1	3.73e-05	199	15	3	34199597371a20d9f1dea9ad59edfb615b14c4f6
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RBBP4 HMGB1 RBBP7	3.73e-05	199	15	3	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	COVID-19-COVID-19_Mild-Myeloid-Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	CRISPLD2 TNFSF10 ACTN1	3.73e-05	199	15	3	9f6b6731186ef399f952a75879eba66fd8ed3494
ToppCell	severe-Neutrophil\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CRISPLD2 TNFSF10 ACTN1	3.79e-05	200	15	3	f9af7e77a8483ab4ae708b55514e64f5420fa0c1
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RBBP4 HMGB1 RBBP7	3.79e-05	200	15	3	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	RBBP4 HMGB1 RBBP7	3.79e-05	200	15	3	5f2fbd789cc16af411a01c3199583888b260ae91
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RBBP4 HMGB1 RBBP7	3.79e-05	200	15	3	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	7.98e-04	126	15	2	c3261ea8726400de87f1c8a5a5134ba2b2884f66
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CRISPLD2 KIAA0753	1.10e-03	148	15	2	5729826e8d45bf995e2efa6707c49e264d12d112
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.10e-03	148	15	2	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.10e-03	148	15	2	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	E16.5-samps\|World / Age Group, Lineage, Cell class and subclass	CDKN1C HMGB1	1.11e-03	149	15	2	e94d075f68c1c70c89fab50b1b765b5dda650d09
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.13e-03	150	15	2	6e806a028c0519489151c181d9907e05289e27e0
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRISPLD2 ACTN1	1.17e-03	153	15	2	65641cc82883716dba0fefb749a30174a63f4da5
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDKN1C CRISPLD2	1.20e-03	155	15	2	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACTN1 SRCAP	1.22e-03	156	15	2	bb505f639dbcad2b788db62d6084c2cb4e884bec
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.23e-03	157	15	2	0673c7161c25feceee8f1e5fd237171576c42c6b
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.23e-03	157	15	2	d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0
ToppCell	droplet-Heart-nan-3m-Endothelial-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C KIAA0753	1.23e-03	157	15	2	d85a2f56ae313baa9738e81d2756ce1fe1ba50db
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRISPLD2 ACTN1	1.31e-03	162	15	2	9c9a63adb692651ea5a52cc77b02c5ce11d0ccea
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ACTN1	1.31e-03	162	15	2	68c40d12689cc1b6c797e6e48173f0110f8144e4
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRISPLD2 ACTN1	1.31e-03	162	15	2	1d29983b22f963b34e72cfd1eec328d2d7c4932f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ACTN1	1.31e-03	162	15	2	735fa3f77b31a4189e431d05c326403c18cbbffb
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRISPLD2 ACTN1	1.33e-03	163	15	2	e526104a3a574ee860078ce7c049e7fec9443f37
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.36e-03	165	15	2	c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.36e-03	165	15	2	4cdd80580d5638fd649280ba3893251c2f898f3f
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.36e-03	165	15	2	9acf03b5a20170721380045b5c268825e8f315dd
ToppCell	droplet-Marrow-BM-1m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.38e-03	166	15	2	758817f38e843db4ef6ab3e2bfb9f1a2075c9af9
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.38e-03	166	15	2	a1211afc1197d078eb3db0d0f788ecaf4419aa5b
ToppCell	droplet-Marrow-BM-30m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.38e-03	166	15	2	019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d
ToppCell	Control-Myeloid-MoAM1,_IL1R2\|Control / Condition, Lineage and Cell class	CRISPLD2 TNFSF10	1.39e-03	167	15	2	ab6029ba037b6a499da8758864c44e174cde5587
ToppCell	Control-Myeloid-MoAM1,_IL1R2\|Myeloid / Condition, Lineage and Cell class	CRISPLD2 TNFSF10	1.39e-03	167	15	2	6e5140527437193f441ca96893b9a00d346614f3
ToppCell	droplet-Spleen-nan-21m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.39e-03	167	15	2	cfcd72292c733cdb18c92fdb61b68f6806d22c8c
ToppCell	(0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte\|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization)	CRISPLD2 ACTN1	1.39e-03	167	15	2	7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4\|TCGA-Lung / Sample_Type by Project: Shred V9	CRISPLD2 ACTN1	1.41e-03	168	15	2	aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCell	healthy_donor-Myeloid-Monocytic-Neutrophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CRISPLD2 ACTN1	1.41e-03	168	15	2	04259f5a9b067cd1b5619e34591e4b2fccc18535
ToppCell	Immune_cells-Neutrophils\|Immune_cells / Lineage and Cell class	CRISPLD2 ACTN1	1.41e-03	168	15	2	3539f802fe0143da1462df0618f78f9f15143f71
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.41e-03	168	15	2	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	e0076aa61b4ef3f836f5750005d0469d3982eb6d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	a5964aef04093b460bbe29d5e2e7389f8fd2d46f
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	2341eddfedaad8cee779c37bb87f7def058588ca
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	f38b52972a6c492ce2fd520a26bb3fc8db23bf85
ToppCell	facs-Marrow-Granulocytes-18m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	94871936ccfc73b56d425373b989b87c059d4493
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	5320da1d61806b53e0bd96bbdfdb8fd69246681b
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	1000eaf5158596b4898bedcc802b31db76b05a48
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.43e-03	169	15	2	83b854fa8fd9017df8f9207d9ced260eee98e8c1
ToppCell	Monocytes-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CDKN1C TNFSF10	1.44e-03	170	15	2	4e93b66b3033e6e4d5f6d2f41974623a53108f5e
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.46e-03	171	15	2	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.46e-03	171	15	2	1701dedf0c18751db6c9fee3d93fff150ed0e17f
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.46e-03	171	15	2	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	droplet-Marrow-BM-1m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.46e-03	171	15	2	8a0c08f0aa3a80cd6346c81deb242e430ebd897b
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.48e-03	172	15	2	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	NS-critical-d_16-33-Epithelial-unknown_epithelial\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CDKN1C CRISPLD2	1.48e-03	172	15	2	c0b5e4889aef2f168d9f6db19a63b24bfd249316
ToppCell	droplet-Marrow-nan-18m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.49e-03	173	15	2	03cee3d24bc433e91a867ce951589de64a0538af
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRISPLD2 ACTN1	1.51e-03	174	15	2	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	droplet-Marrow-nan-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.51e-03	174	15	2	4b749ac9f05776c0c56b74daca833bd0b5704299
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CRISPLD2 ACTN1	1.53e-03	175	15	2	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.55e-03	176	15	2	99410c121f55adbc7fcc013c8fa8905a45dba76b
ToppCell	facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.55e-03	176	15	2	fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8
ToppCell	droplet-Marrow-nan-21m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.55e-03	176	15	2	f7d8eb90489a6d22240179abeb0aa16ac24615d3
ToppCell	facs-Heart-RV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.55e-03	176	15	2	3270a36fc91a5583646ffeb70bfcbc5af7292aac
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.56e-03	177	15	2	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.56e-03	177	15	2	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDKN1C CRISPLD2	1.56e-03	177	15	2	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-inner_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C ACTN1	1.60e-03	179	15	2	142457c98656ed389461e081e0e6d03e86d2fb1a
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CRISPLD2 ACTN1	1.60e-03	179	15	2	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	Lymphoid-Lymphoid-T_cells_(cycle)\|Lymphoid / shred on cell class and cell subclass (v4)	HMGB1 RBBP7	1.63e-03	181	15	2	b6b41cd5d43543fe7a093033dae52a789199db0e
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD8_Naive\|Leuk-UTI / Disease, Lineage and Cell Type	RBBP7 ACTN1	1.65e-03	182	15	2	3500a826d86beb98980e2b24e074b02e8e2f957e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ACTN1	1.65e-03	182	15	2	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid\|bone_marrow / Manually curated celltypes from each tissue	HMGB1 ACTN1	1.65e-03	182	15	2	6745d464c3ff289726aa8164e9a43f407f8e4380
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRISPLD2 ACTN1	1.65e-03	182	15	2	7b86703559438e2d5ef3dad963ee0d772513f313
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ACTN1	1.65e-03	182	15	2	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRISPLD2 ACTN1	1.65e-03	182	15	2	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRISPLD2 ACTN1	1.67e-03	183	15	2	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ACTN1	1.67e-03	183	15	2	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.69e-03	184	15	2	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	droplet-Heart-4Chambers-21m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.69e-03	184	15	2	f17d713af4a97dff4eeeab24c405677ef2ffcf84
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.69e-03	184	15	2	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRISPLD2 ACTN1	1.70e-03	185	15	2	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.70e-03	185	15	2	ff38a15af3dec36d9993f06623591872b5d1da9a
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.70e-03	185	15	2	98547c1b1828b76da810ed86082182afaaacdb3f
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGB1 ACTN1	1.70e-03	185	15	2	7acc071ea75442817db4d98bd3ed3fff6f0a9d46
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.70e-03	185	15	2	eaa54b76743628c89b4310be57b87fa92b75fd37
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.70e-03	185	15	2	f7f4c921d248c637351e2e882589b99ba7f04b66
ToppCell	droplet-Heart-nan-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.70e-03	185	15	2	a32d5cb596ebac80eb1ac301055e65d420879ec8
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 ACTN1	1.70e-03	185	15	2	5f5df92b328be396941b5812d00454b5ff927d30
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGB1 ACTN1	1.70e-03	185	15	2	aa2c36e2cce0f0a536cd1dfc3788b6fee6f21b6b
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.72e-03	186	15	2	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HMGB1 RBBP7	1.72e-03	186	15	2	86d145f965c311189e7996390eef491642417c5c
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C CRISPLD2	1.72e-03	186	15	2	ff6ccfdf2509f96caa10281c29a95b432f6c6dcc
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	CDKN1C CRISPLD2	1.72e-03	186	15	2	a16ecf70271894a842925f232009e2623d16947e
ToppCell	facs-Heart-LA-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C TNFSF10	1.74e-03	187	15	2	7b13c3b67d66f3afb410141d5471c9e78a4d8623
ToppCell	facs-Brain_Non-Myeloid-Cortex_\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD2 HMGB1	1.74e-03	187	15	2	e082499077f1ef317622576ee85dec2c05796e61
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A	CDKN1C NMT1 TNFSF10 SRCAP	4.98e-06	196	14	4	6653_DN
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; HL60; HT_HG-U133A	NMT1 CRISPLD2 TNFSF10 SRCAP	5.08e-06	197	14	4	2557_DN
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	NMT1 SMARCC2 STX12 SRCAP	5.19e-06	198	14	4	169_DN
Drug	AC1OC6D1	RBBP4 SMARCC2 RBBP7	3.25e-05	104	14	3	CID006368594
Drug	tanshinone	TNFSF10 HMGB1	3.67e-05	15	14	2	CID000114917
Drug	oxaliplatin	TNFSF10 HMGB1 TGDS	1.22e-04	162	14	3	CID000004609
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.45e-04	172	14	3	5580_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.48e-04	173	14	3	1659_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.48e-04	173	14	3	4112_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.48e-04	173	14	3	5594_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.50e-04	174	14	3	5572_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.50e-04	174	14	3	5231_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.53e-04	175	14	3	3428_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.53e-04	175	14	3	5417_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.58e-04	177	14	3	6980_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.58e-04	177	14	3	4768_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.63e-04	179	14	3	6951_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.63e-04	179	14	3	6993_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.66e-04	180	14	3	5484_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 STX12	1.71e-04	182	14	3	6932_UP
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	CDKN1C NMT1 KIAA0753	1.95e-04	190	14	3	5080_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A	CDKN1C NMT1 TNFSF10	1.98e-04	191	14	3	1240_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; SKMEL5; HG-U133A	CDKN1C SMARCC2 STX12	2.01e-04	192	14	3	629_UP
Drug	PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A	CDKN1C TNFSF10 SRCAP	2.01e-04	192	14	3	5967_UP
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	NMT1 TNFSF10 SRCAP	2.04e-04	193	14	3	4712_UP
Drug	Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; PC3; HG-U133A	NMT1 SMARCC2 KIAA0753	2.07e-04	194	14	3	1905_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	SMARCC2 ACTN1 KIAA0753	2.10e-04	195	14	3	1296_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A	CRISPLD2 SMARCC2 SRCAP	2.10e-04	195	14	3	7435_UP
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; HL60; HT_HG-U133A	NMT1 TNFSF10 SRCAP	2.10e-04	195	14	3	3001_DN
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MSANTD2 SMARCC2 SRCAP	2.10e-04	195	14	3	6255_DN
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	CRISPLD2 MSANTD2 KIAA0753	2.10e-04	195	14	3	4660_DN
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A	CDKN1C CRISPLD2 SRCAP	2.10e-04	195	14	3	7448_UP
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A	CRISPLD2 HMGB1 ACTN1	2.13e-04	196	14	3	1840_UP
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	TNFSF10 KIAA0753 SRCAP	2.13e-04	196	14	3	2372_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	NMT1 SMARCC2 SRCAP	2.13e-04	196	14	3	1821_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A	CDKN1C NMT1 KIAA0753	2.13e-04	196	14	3	4645_DN
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A	CRISPLD2 KIAA0753 SRCAP	2.13e-04	196	14	3	2390_DN
Drug	Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	CDKN1C TNFSF10 SRCAP	2.13e-04	196	14	3	4685_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NMT1 SMARCC2 SRCAP	2.13e-04	196	14	3	4993_DN
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	CDKN1C NMT1 SRCAP	2.13e-04	196	14	3	2249_DN
Drug	LY294002; Down 200; 10uM; PC3; HG-U133A	NMT1 ACTN1 STX12	2.13e-04	196	14	3	461_DN
Drug	rofecoxib; Down 200; 10uM; PC3; HG-U133A	NMT1 SMARCC2 STX12	2.16e-04	197	14	3	463_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A	CDKN1C TNFSF10 SRCAP	2.16e-04	197	14	3	5751_UP
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HG-U133A	SMARCC2 ACTN1 STX12	2.16e-04	197	14	3	121_UP
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; PC3; HT_HG-U133A	CDKN1C NMT1 KIAA0753	2.16e-04	197	14	3	6622_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	CDKN1C NMT1 SRCAP	2.16e-04	197	14	3	1237_UP
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; HL60; HG-U133A	MSANTD2 SMARCC2 SRCAP	2.16e-04	197	14	3	1371_UP
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HG-U133A	NMT1 STX12 SRCAP	2.16e-04	197	14	3	365_UP
Drug	Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A	NMT1 SMARCC2 SRCAP	2.20e-04	198	14	3	7372_DN
Drug	benserazide hydrochloride; Up 200; 10uM; SKMEL5; HG-U133A	SMARCC2 STX12 KIAA0753	2.20e-04	198	14	3	631_UP
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A	CDKN1C SMARCC2 KIAA0753	2.20e-04	198	14	3	7243_DN
Drug	iloprost; Up 200; 1uM; MCF7; HG-U133A	SMARCC2 ACTN1 SRCAP	2.20e-04	198	14	3	488_UP
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; HL60; HG-U133A	NMT1 MSANTD2 TNFSF10	2.20e-04	198	14	3	1719_UP
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	CDKN1C SMARCC2 ACTN1	2.23e-04	199	14	3	61_DN
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A	NMT1 TNFSF10 SRCAP	2.23e-04	199	14	3	5412_UP
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	NMT1 TNFSF10 SRCAP	2.23e-04	199	14	3	4375_DN
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	SMARCC2 KIAA0753 SRCAP	2.23e-04	199	14	3	6319_DN
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; PC3; HG-U133A	NMT1 SMARCC2 KIAA0753	2.23e-04	199	14	3	457_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	NMT1 KIAA0753 SRCAP	2.23e-04	199	14	3	6168_DN
Drug	CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A	CDKN1C TNFSF10 SRCAP	2.26e-04	200	14	3	3825_UP
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	CRISPLD2 SMARCC2 KIAA0753	2.26e-04	200	14	3	2061_DN
Drug	DB04790	TNFSF10 RBBP7	2.70e-04	40	14	2	CID005326924
Drug	7,3'-dihydroxy-4'-methoxyisoflavone	CDKN1C HMGB1	3.58e-04	46	14	2	ctd:C121707
Drug	Vincristine	TNFSF10 RBBP4 HMGB1 STX12 TGDS	5.05e-04	1182	14	5	ctd:D014750
Drug	trapoxin	RBBP4 RBBP7	5.69e-04	58	14	2	CID000121875
Drug	kt S	CDKN1C ACTN1	7.36e-04	66	14	2	CID006399216
Drug	A25618	CDKN1C TNFSF10 RBBP4 RBBP7	1.02e-03	777	14	4	CID000005562
Drug	AC1L2I7Q	CDKN1C NMT1	1.16e-03	83	14	2	CID000072513
Drug	NSC302991	TNFSF10 TGDS SRCAP	1.18e-03	353	14	3	CID000002538
Drug	lotion	RBBP4 RBBP7	1.19e-03	84	14	2	CID000001176
Drug	manganese(III)-tetrakis(4-benzoic acid)porphyrin	TNFSF10 HMGB1	1.19e-03	84	14	2	ctd:C097284
Drug	NSC298883	CDKN1C HMGB1	1.33e-03	89	14	2	CID000326807
Drug	Demecolcine	TNFSF10 RBBP4 SMARCC2 STX12	1.61e-03	878	14	4	ctd:D003703
Drug	tert-butyl hydroperoxide	CDKN1C CRISPLD2 SMARCC2 ACTN1	1.78e-03	902	14	4	CID000006410
Drug	Isoflurane	TNFSF10 HMGB1	1.81e-03	104	14	2	ctd:D007530
Drug	Mitomycin	TNFSF10 RBBP7 TGDS	1.82e-03	410	14	3	ctd:D016685
Drug	Asbestos, Serpentine	CRISPLD2 TNFSF10 HMGB1	2.39e-03	451	14	3	ctd:D017632
Disease	Endometrial Neoplasms	CDKN1C TNFSF10	2.92e-04	58	13	2	C0014170
Disease	Endometrial Carcinoma	CDKN1C TNFSF10	4.50e-04	72	13	2	C0476089
Disease	carotid plaque build	TNFSF10 HMGB1	6.12e-04	84	13	2	EFO_0006501
Disease	very low density lipoprotein particle size measurement	HMGB1 TGDS	1.52e-03	133	13	2	EFO_0008594
Disease	testosterone measurement	TNFSF10 KIAA0753 TGDS SRCAP	1.81e-03	1275	13	4	EFO_0004908
Disease	gait measurement	NMT1 TNFSF10	1.93e-03	150	13	2	EFO_0007680
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TNFSF10 TGDS	3.39e-03	200	13	2	EFO_0004611, EFO_0020945
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	HMGB1 TGDS	4.24e-03	224	13	2	EFO_0004530, EFO_0008317
Disease	cancer (implicated_via_orthology)	SMARCC2 STX12	6.00e-03	268	13	2	DOID:162 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQQTNDYMQPEEDWD	ACTN1	6	P12814
MEDYSQEDWGNHSQD	MSANTD2	231	Q6P1R3
EMWNNTAADDKQPYE	HMGB1	131	P09429
MSQEEVEHWFYPQEN	NMT1	366	P30419
QPQASNMEYMTWDDE	CRISPLD2	71	Q9H0B8
VWQMAENIYNDEDPE	RBBP4	401	Q09028
WQMAENIYNDEESDV	RBBP7	401	Q16576
EDQNRWDYDFQQDMP	CDKN1C	56	P49918
SQDIDDDMNWYQQKP	IGKV5-2	46	P06315
YADPRLWMQEENNDQ	KIAA0753	801	Q2KHM9
YDSDWNPTMDAQAQD	SRCAP	2136	Q6ZRS2
DTFNEWMNEEDYEVN	SMARCC2	246	Q8TAQ2
ENWVDYVNDRPTNDM	TGDS	286	O95455
DSHEEWNQMQSQEDE	STX12	156	Q86Y82
DDSYWDPNDEESMNS	TNFSF10	61	P50591